SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-24-022591
Filing Date
2024-06-04
Accepted
2024-06-04 17:24:37
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 102415
2 logo_01.jpg GRAPHIC 36155
  Complete submission text file 0001493152-24-022591.txt   153501
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-276741 | Film No.: 241019555
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)